Key facts
- Notable investors include Hongsheng Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Noah Source Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Noah Source Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Noah Source Medical
Manufacturer of full-spectrum flow cytometers designed for clinical research and healthcare application purposes. The company offers molecular diagnostics, bioinformatics analysis, laboratory automation, and data-driven evaluation frameworks with compliance to medical standards, enabling healthcare and research markets to achieve accurate testing, structured data management, reliable experimental workflows, enhanced efficiency, scalable deployment, and improved support for translational medicine across diverse clinical and scientific environments.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2024
- Website
- nokayun.cn/
- Ownership
- Privately Held (backing)
Noah Source Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Noah Source Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Noah Source Medical in its N-PORT filings yet. We sweep new filings monthly.